Literature DB >> 17720186

Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.

Mahesh P Gupta1.   

Abstract

Myosin is a molecular motor, which interacts with actin to convert the energy from ATP hydrolysis into mechanical work. In cardiac myocytes, two myosin isoforms are expressed and their relative distribution changes in different developmental and pathophysiologic conditions of the heart. It has been realized for a long time that a shift in myosin isoforms plays a major role in regulating myocardial contractile activity. With the recent evidence implicating that alteration in myosin isoform ratio may be eventually beneficial for the treatment of a stressed heart, a new interest has developed to find out ways of controlling the myosin isoform shift. This article reviews the published data describing the role of myosin isoforms in the heart and highlighting the importance of various factors shown to influence myosin isofrom shift during physiology and disease states of the heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720186      PMCID: PMC2701247          DOI: 10.1016/j.yjmcc.2007.07.045

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  152 in total

1.  Analysis of myosin heavy chain functionality in the heart.

Authors:  Maike Krenz; Atsushi Sanbe; Florence Bouyer-Dalloz; James Gulick; Raisa Klevitsky; Timothy E Hewett; Hanna E Osinska; John N Lorenz; Christine Brosseau; Andrea Federico; Norman R Alpert; David M Warshaw; M Benjamin Perryman; Steve M Helmke; Jeffrey Robbins
Journal:  J Biol Chem       Date:  2003-03-06       Impact factor: 5.157

2.  Hypoxia-induced switches of myosin heavy chain iso-gene expression in rat heart.

Authors:  Peter Razeghi; M Faadiel Essop; Janice M Huss; Shahrzad Abbasi; Nayna Manga; Heinrich Taegtmeyer
Journal:  Biochem Biophys Res Commun       Date:  2003-04-18       Impact factor: 3.575

3.  Myosin from failing and non-failing human ventricles exhibit similar contractile properties.

Authors:  Teruo Noguchi; Phillip Camp; Shari L Alix; Joseph A Gorga; Kelly J Begin; Bruce J Leavitt; Frank P Ittleman; Norman R Alpert; Martin M LeWinter; Peter VanBuren
Journal:  J Mol Cell Cardiol       Date:  2003-01       Impact factor: 5.000

Review 4.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

5.  Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy.

Authors:  Francesca J Davis; Madhu Gupta; Blanca Camoretti-Mercado; Robert J Schwartz; Mahesh P Gupta
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

6.  Molecular mechanics of mouse cardiac myosin isoforms.

Authors:  Norman R Alpert; Christine Brosseau; Andrea Federico; Maike Krenz; Jeffrey Robbins; David M Warshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-10       Impact factor: 4.733

7.  Basal and alpha1-adrenergic-induced activity of minimal rat betaMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites.

Authors:  B Gail McLean; Katherine S Lee; Paul C Simpson; Iain K G Farrance
Journal:  J Mol Cell Cardiol       Date:  2003-05       Impact factor: 5.000

8.  Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

Authors:  Chun Li Zhang; Timothy A McKinsey; Shurong Chang; Christopher L Antos; Joseph A Hill; Eric N Olson
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

9.  Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure.

Authors:  Eugene Morkin; Gregory Pennock; Peter H Spooner; Joseph J Bahl; Katherine Underhill Fox; Steven Goldman
Journal:  Cardiology       Date:  2002       Impact factor: 1.869

10.  New microRNAs from mouse and human.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Jutta Meyer; Arndt Borkhardt; Thomas Tuschl
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

View more
  87 in total

1.  Adaptive thermogenesis and thermal conductance in wild-type and UCP1-KO mice.

Authors:  Carola W Meyer; Monja Willershäuser; Martin Jastroch; Bryan C Rourke; Tobias Fromme; Rebecca Oelkrug; Gerhard Heldmaier; Martin Klingenspor
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-08       Impact factor: 3.619

2.  Fluorescence spectra of cardiac myosin and in vivo experiment: studies on daunorubicin-induced cardiotoxicity.

Authors:  Yang Liu; Chi Chen; Xiaoxiang Duan; Wenting Ma; Man Wang; Mengyi Tu; Ying Chen
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

3.  Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip.

Authors:  Megan L McCain; Sean P Sheehy; Anna Grosberg; Josue A Goss; Kevin Kit Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

4.  Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping.

Authors:  Matthew L Bell; Massimo Buvoli; Leslie A Leinwand
Journal:  Mol Cell Biol       Date:  2010-02-12       Impact factor: 4.272

5.  Obesity-induced cardiac dysfunction: pre-natal vs. post-natal nurture.

Authors:  Virginia S Hahn; Giulio Agnetti
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

6.  Effect of fetal hypothyroidism on MyomiR network and its target gene expression profiles in heart of offspring rats.

Authors:  Nasibeh Yousefzadeh; Sajad Jeddi; Rafighe Ghiasi; Mohammad Reza Alipour
Journal:  Mol Cell Biochem       Date:  2017-06-28       Impact factor: 3.396

7.  Histone Deacetylase 3 (HDAC3)-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity.

Authors:  Sadhana A Samant; Vinodkumar B Pillai; Nagalingam R Sundaresan; Sanjeev G Shroff; Mahesh P Gupta
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

8.  Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice.

Authors:  Pamela Harding; Xiao-Ping Yang; James Yang; Ed Shesely; Quan He; Margot C LaPointe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

9.  Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function.

Authors:  Asmaà Fritah; Jennifer H Steel; Donna Nichol; Nadeene Parker; Sharron Williams; Anthony Price; Leena Strauss; Timothy A Ryder; Margaret A Mobberley; Matti Poutanen; Malcolm Parker; Roger White
Journal:  Cardiovasc Res       Date:  2010-01-18       Impact factor: 10.787

Review 10.  Cardiac hypertrophy and thyroid hormone signaling.

Authors:  Wolfgang Dillmann
Journal:  Heart Fail Rev       Date:  2009-01-06       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.